SIRS-Lab Acquires Rights of Use to OGT Biochip Technology

The biotech company SIRS-Lab and the Oxford Gene Technology IP have agreed on the licensing of OGT's technology for nucleotide-based biochips. The contract signed in January enables SIRS-Lab to produce biochips using the patented technology and to distribute these products and related services Europe-wide.

Le Figaro (http://bourse.lefigaro.fr/Actualite/Default.asp?Source=PR&NumArticle=99551)